Ausper Biopharma Co., Ltd.
Clinical trials sponsored by Ausper Biopharma Co., Ltd., explained in plain language.
-
New shot aims to silence hepatitis b for good
Disease control Recruiting nowThis study tests an experimental injection called AHB-137 in 60 adults with chronic hepatitis B who have already been treated with standard antiviral pills. The goal is to see if the injection can keep the virus undetectable in the blood even after stopping all hepatitis B medica…
Phase: PHASE2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Hepatitis b drug AHB-137: can it keep the virus at bay Long-Term?
Disease control Recruiting nowThis study follows 200 people with chronic hepatitis B who previously responded to the drug AHB-137. Researchers want to see if the virus stays suppressed over time without needing more treatment. Participants will have regular blood tests to monitor hepatitis B levels and liver …
Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC